Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 187INDUSTRY 171NIH 14OTHER_GOV 4FED 2UNKNOWN 1NETWORK 1INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3Thoracic 2Lymphoid 2Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Nasopharyngeal Carcinoma 4Head and Neck Neoplasms 4Vomiting 2Thyroid Neoplasms 1Radiation Injuries 1Neoplasms 1Neoplasm Metastasis 1Nausea 1Nasopharyngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hyperparathyroidism, Primary 1Hypercalcemia 1Head and Neck Squamous Cell Cancer 1

Interventions

apatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Neoplasms × Head & Neck × Clear all
NCT03199677 2017-07-02

A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer

ChineseAMS

Phase 2 Unknown
40 enrolled
Head & Neck

Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡